- Home
- HP vs DNTH Comparison
HP vs DNTH Comparison
Compare HP & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HP
- DNTH
- Stock Information
- Founded
- HP 1920
- DNTH 2015
- Country
- HP United States
- DNTH United States
- Employees
- HP N/A
- DNTH N/A
- Industry
- HP Oil & Gas Production
- DNTH Biotechnology: Pharmaceutical Preparations
- Sector
- HP Energy
- DNTH Health Care
- Exchange
- HP Nasdaq
- DNTH Nasdaq
- Market Cap
- HP 1.6B
- DNTH 1.5B
- IPO Year
- HP N/A
- DNTH N/A
- Fundamental
- Price
- HP $23.06
- DNTH $34.94
- Analyst Decision
- HP Hold
- DNTH Strong Buy
- Analyst Count
- HP 12
- DNTH 10
- Target Price
- HP $22.45
- DNTH $66.38
- AVG Volume (30 Days)
- HP 1.7M
- DNTH 1.2M
- Earning Date
- HP 11-12-2025
- DNTH 11-06-2025
- Dividend Yield
- HP 4.33%
- DNTH N/A
- EPS Growth
- HP N/A
- DNTH N/A
- EPS
- HP N/A
- DNTH N/A
- Revenue
- HP $3,428,058,000.00
- DNTH $4,854,000.00
- Revenue This Year
- HP $38.03
- DNTH N/A
- Revenue Next Year
- HP $3.73
- DNTH N/A
- P/E Ratio
- HP N/A
- DNTH N/A
- Revenue Growth
- HP 25.92
- DNTH 17.87
- 52 Week Low
- HP $14.65
- DNTH $13.37
- 52 Week High
- HP $37.46
- DNTH $40.16
- Technical
- Relative Strength Index (RSI)
- HP 65.57
- DNTH 52.98
- Support Level
- HP $21.66
- DNTH $35.50
- Resistance Level
- HP $23.59
- DNTH $40.16
- Average True Range (ATR)
- HP 0.88
- DNTH 2.17
- MACD
- HP 0.04
- DNTH -0.68
- Stochastic Oscillator
- HP 83.79
- DNTH 5.95
About HP Helmerich & Payne Inc.
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies that are intended to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. The Company focus on the drilling segment of the oil and gas production value chain. Company operates in North America, Gulf of Mexico, and other international places such as Argentina, Australia, Bahrain, Colombia and the United Arab Emirates (UAE). Also own and operates a limited number of commercial real estate properties located in Tulsa, Oklahoma. It's real estate investments include a shopping center and of undeveloped real estate projects.
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.